These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 32157995)

  • 1. Evaluation of Implementation of Intermittent Screening and Treatment for Control of Malaria in Pregnancy in Jharkhand, India.
    Webster J; Mishra VK; Anvikar AR; Kuepfer I; Hoyt J; Bruce J; Greenwood B; Chandramohan D; Valecha N; Mishra N
    Am J Trop Med Hyg; 2020 Jun; 102(6):1343-1350. PubMed ID: 32157995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intermittent screening and treatment with dihydroartemisinin-piperaquine for the prevention of malaria in pregnancy: implementation feasibility in a routine healthcare system setting in western Kenya.
    Hill J; Ouma P; Oluoch S; Bruce J; Kariuki S; Desai M; Webster J
    Malar J; 2020 Nov; 19(1):433. PubMed ID: 33238999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Healthcare provider and pregnant women's perspectives on the implementation of intermittent screening and treatment with dihydroartemisinin-piperaquine for malaria in pregnancy in western Kenya: a qualitative study.
    Hoyt J; Hill J; Achieng F; Ouma P; Kariuki S; Desai M; Webster J
    Malar J; 2021 Jun; 20(1):291. PubMed ID: 34187458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. User and Provider Acceptability of Intermittent Screening and Treatment and Intermittent Preventive Treatment with Dihydroartemisinin-Piperaquine to Prevent Malaria in Pregnancy in Western Kenya.
    Hill J; Hoyt J; Achieng F; Ouma P; L'lanziva A; Kariuki S; Desai M; Webster J
    PLoS One; 2016; 11(3):e0150259. PubMed ID: 26986471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of Intermittent Screening and Treatment of Malaria in Pregnancy on Maternal and Birth Outcomes in Selected Districts in Rwanda: A Cluster Randomized Controlled Trial.
    Uwimana A; Sethi R; Murindahabi M; Ntirandeka C; Piercefield E; Umulisa N; Abram A; Eckert E; Munguti K; Sullivan D; Uyizeye D; Mbituyumuremyi A; Gutman JR
    Clin Infect Dis; 2023 Jul; 77(1):127-134. PubMed ID: 36896967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of a single screen and treat strategy to detect asymptomatic malaria among pregnant women from selected health facilities in Lindi region, Tanzania.
    Kitojo C; Chacky F; Kigadye ES; Mugasa JP; Lusasi A; Mohamed A; Walker P; Reaves EJ; Gutman JR; Ishengoma DS
    Malar J; 2020 Nov; 19(1):438. PubMed ID: 33256758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intermittent screening and treatment or intermittent preventive treatment compared to current policy of single screening and treatment for the prevention of malaria in pregnancy in Eastern Indonesia: acceptability among health providers and pregnant women.
    Hoyt J; Landuwulang CUR; Ansariadi ; Ahmed R; Burdam FH; Bonsapia I; Poespoprodjo JR; Syafruddin D; Ter Kuile FO; Webster J; Hill J
    Malar J; 2018 Sep; 17(1):341. PubMed ID: 30261877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acceptability of single screening and treatment policy for the control of malaria in pregnancy: perceptions of providers and pregnant women from selected health facilities in Lindi region, Tanzania.
    Kitojo C; Chacky F; Kigadye ES; Mugasa JP; Lusasi A; Mohamed A; Reaves EJ; Gutman JR; Ishengoma DS
    Malar J; 2021 Jun; 20(1):256. PubMed ID: 34103047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intermittent screening and treatment with artemether-lumefantrine versus intermittent preventive treatment with sulfadoxine-pyrimethamine for malaria in pregnancy: a facility-based, open-label, non-inferiority trial in Nigeria.
    Esu E; Berens-Riha N; Pritsch M; Nwachuku N; Loescher T; Meremikwu M
    Malar J; 2018 Jul; 17(1):251. PubMed ID: 29976228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Provider and user acceptability of intermittent screening and treatment for the control of malaria in pregnancy in Malawi.
    Almond D; Madanitsa M; Mwapasa V; Kalilani-Phiri L; Webster J; Ter Kuile F; Paintain L
    Malar J; 2016 Nov; 15(1):574. PubMed ID: 27894353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of group versus individual antenatal care on uptake of intermittent prophylactic treatment of malaria in pregnancy and related malaria outcomes in Nigeria and Kenya: analysis of data from a pragmatic cluster randomized trial.
    Noguchi L; Grenier L; Kabue M; Ugwa E; Oyetunji J; Suhowatsky S; Onguti B; Orji B; Whiting-Collins L; Adetiloye O
    Malar J; 2020 Jan; 19(1):51. PubMed ID: 31996209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Uptake of intermittent preventive treatment for malaria during pregnancy with Sulphadoxine-Pyrimethamine in Malawi after adoption of updated World Health Organization policy: an analysis of demographic and health survey 2015-2016.
    Azizi SC
    BMC Public Health; 2020 Mar; 20(1):335. PubMed ID: 32178658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between timing and number of antenatal care visits on uptake of intermittent preventive treatment for malaria during pregnancy among Malawian women.
    Nkoka O; Chuang TW; Chen YH
    Malar J; 2018 May; 17(1):211. PubMed ID: 29793482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomised trial of alternative malaria chemoprophylaxis strategies among pregnant women in Kigoma, Tanzania: II. Results from baseline studies.
    Mnyika SK; Kabalimu TK; Mbaruku G; Masisila R; Mpanju-Shumbusho W
    East Afr Med J; 2000 Feb; 77(2):105-10. PubMed ID: 10774084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Attitudes, knowledge, and practices regarding malaria prevention and treatment among pregnant women in Eastern India.
    Sabin LL; Rizal A; Brooks MI; Singh MP; Tuchman J; Wylie BJ; Joyce KM; Yeboah-Antwi K; Singh N; Hamer DH
    Am J Trop Med Hyg; 2010 Jun; 82(6):1010-6. PubMed ID: 20519593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of intermittent screening and treatment for the control of malaria in pregnancy: a cluster randomised trial in India.
    Kuepfer I; Mishra N; Bruce J; Mishra V; Anvikar AR; Satpathi S; Behera P; Muehlenbachs A; Webster J; terKuile F; Greenwood B; Valecha N; Chandramohan D
    BMJ Glob Health; 2019; 4(4):e001399. PubMed ID: 31406586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intermittent preventive treatment of malaria in pregnancy: a cross-sectional survey to assess uptake of the new sulfadoxine-pyrimethamine five dose policy in Ghana.
    Owusu-Boateng I; Anto F
    Malar J; 2017 Aug; 16(1):323. PubMed ID: 28797296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of intermittent preventive treatment with sulphadoxine-pyrimethamine (IPTp-SP) use during pregnancy and other associated factors in Sekondi-Takoradi, Ghana.
    Orish VN; Onyeabor OS; Boampong JN; Afoakwah R; Nwaefuna E; Acquah S; Sanyaolu AO; Iriemenam NC
    Afr Health Sci; 2015 Dec; 15(4):1087-96. PubMed ID: 26958008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uptake of intermittent preventive treatment for malaria during pregnancy with Sulphadoxine-Pyrimethamine (IPTp-SP) among postpartum women in Zomba District, Malawi: a cross-sectional study.
    Azizi SC; Chongwe G; Chipukuma H; Jacobs C; Zgambo J; Michelo C
    BMC Pregnancy Childbirth; 2018 Apr; 18(1):108. PubMed ID: 29678150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Malaria-related ideational factors and other correlates associated with intermittent preventive treatment among pregnant women in Madagascar.
    Awantang GN; Babalola SO; Koenker H; Fox KA; Toso M; Lewicky N
    Malar J; 2018 Apr; 17(1):176. PubMed ID: 29695231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.